KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insulet (PODD) Receivables (2016 - 2026)

Insulet filings provide 16 years of Receivables readings, the most recent being $516.9 million for Q4 2025.

  • On a quarterly basis, Receivables rose 357.43% to $516.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $516.9 million, a 357.43% increase, with the full-year FY2025 number at $516.9 million, up 357.43% from a year prior.
  • Receivables hit $516.9 million in Q4 2025 for Insulet, up from $9.1 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $516.9 million in Q4 2025 to a low of $5.8 million in Q4 2023.
  • Median Receivables over the past 5 years was $181.9 million (2022), compared with a mean of $179.2 million.
  • Biggest five-year swings in Receivables: tumbled 97.18% in 2023 and later soared 4471.88% in 2025.
  • Insulet's Receivables stood at $161.0 million in 2021, then increased by 27.7% to $205.6 million in 2022, then tumbled by 97.18% to $5.8 million in 2023, then surged by 1848.28% to $113.0 million in 2024, then soared by 357.43% to $516.9 million in 2025.
  • The last three reported values for Receivables were $516.9 million (Q4 2025), $9.1 million (Q3 2025), and $292.6 million (Q2 2025) per Business Quant data.